PETALING JAYA: The Health Ministry has not received any submissions for clinical studies and trials for the use of medical marijuana but would welcome it, says Khairy Jamaluddin.

       “Much discussion of late on medicinal use of marijuana. @KKMPutrajaya has been consistent in practising evidence-based policies. That’s why we have welcomed clinical studies for the use of CBD(Cannabidiol ) for medicinal purposes. This can be coordinated by @ICR_NIH & @ClinicalRsrchMY,” he said in a tweet on Wednesday (April 6).

       “So far, there have been no full submissions for a clinical study/trial. Much expressions of interest, talk and social media advocacy.

       “@KKMPutrajaya welcomes industry or academia initiated research for the medicinal use of CBD. We are ready to collaborate,” he said.

       Khairy said on Nov 17 that the ministry welcomes clinical trials to ascertain the quality and efficacy of medical cannabis products in Malaysia.

       He added that the present laws on cannabis such as the Control of Drugs and Cosmetic Regulations 1984, Poison Act 195 and the Dangerous Drugs Act 1952 do not forbid the use of cannabis for medical purposes.

       “If there are any parties with adequate scientific evidence who want to use cannabis for medical purposes - taking into account the quality, safety and efficacy aspects - they can apply to the local Drug Control Authority (DCA) for evaluation.

       “It will then be registered under the Control of Drugs and Cosmetic Regulations 1984 and can be sold in Malaysia.”

       Much discussion of late on medicinal use of marijuana. @KKMPutrajaya has been consistent in practicing evidence-based policies. That’s why we have welcomed clinical studies for the use of CBD for medicinal purposes. This can be coordinated by @ICR_NIH & @ClinicalRsrchMY.

       — Khairy Jamaluddin ？？？ (@Khairykj) April 6, 2022 So far, there have been no full submissions for a clinical study/trial. Much expressions of interest, talk and social media advocacy. @KKMPutrajaya welcomes industry or academia initiated research for the medicinal use of CBD. We are ready to collaborate.

       — Khairy Jamaluddin ？？？ (@Khairykj) April 6, 2022